The pharmacologic treatment of the alcohol dependence;Tratamento farmacológico da dependência do álcool

Revista Brasileira de Psiquiatria

Volumn 26, Issue SUPPL., 2004, Pages 43-46

  Castro, Luís André ^a,c   Baltieri, Danilo Antonio ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Alcoholism; Disulfiram; Naltrexone

Indexed keywords

ACAMPROSATE; DISULFIRAM; NALTREXONE; ONDANSETRON; PLACEBO; TOPIRAMATE;

ABDOMINAL PAIN; ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL TRIAL; CONFUSION; DRINKING BEHAVIOR; DRUG CONTRAINDICATION; GABAERGIC SYSTEM; HUMAN; HYPERCALCEMIA; LIBIDO DISORDER; LIVER TOXICITY; NAUSEA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRURITUS; RASH; RELAPSE; REVIEW; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING;

EID: 2642557036     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462004000500011     Document Type: Review

References (21)

1. Swift RM, Davidson D, Whelihan W, Kuznetsov O. Ondansetron alters human alcohol intoxication. Biol Psychiatry 1996;40:514-21.
2. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial The Lancet 2003;361:1677-85.
3. Azrin NH, Sisson RW, Meyers RE, Godley M. Alcoholism treatment by disulfiram and community reinforcement therapy. J Behav Ther Exp Psychiatry 1982;15:105-12.
4. Chick J, Erickson CK. Conference summary: consensus conference on alcohol dependence and the role of pharmacotherapy in its treatment. Alcohol Clin Exp Res 1996;20(2):391-402.
5. McNichol RW, Sowell JM, Longsdon SA, Delgado MH, McNichol J. Disulfiram: a guide to clinical use in alcoholism treatment. Am Fam Physician 1991;44:481-4.
6. Meyer RE. Prospects for a rational pharmacotherapy of alcoholism. J Clin Psychiatry 1989;50(11):405-12.
7. Srisurapanont M, Jarusuraisin N. Opioid antagonists for alcohol dependence (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford, England: Update Software; 2001.
8. O'Malley SS, Jaffe AJ, Chang G, et al. Six month follow-up of naltrexone and psychotherapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1996;53:217-24.
9. Anton RF, Moak DH, Waid R, Lathan PK,; Malcolm RJ, Dias JK Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo controlled trial Am J Psychiatry 1999;156:1758-64.
10. Latt NC, Jurd S, Houseman J, Wutzke SE. Naltrexone in alcohol dependence: a randomized controlled trial of effectiveness in a standard clinical setting. MJA 2002;176:530-4.
11. Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction 1997;92(11):1537-46.
12. Naassila M, Hammoumi S, Legrand E, Durbin P, Daoust M. Mechanism of action of acamprosate. Part I. Characterization of spermide-sensitive acamprosate binding site in rat brain. Alc Clin Exp Res 1998;22(4):802-9.
13. Putzke J, Spanagel R; Tölle TR, Zieglgänsberger W. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. Eur J Pharmacol 1996;317(1):39-48.
14. Daoust M, Legrand E, Gewiss M, Heidbreder C, Dewitte P, Tran G, et al. Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmacol Biochem Behav 1992;41(4):669-74.
15. Stromberg MF, Mackler AS, Volpicelli JR, O'Brien CP. Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol 2001;23(2):109-16.
16. Saivin S, Hulot T, Chabac S, Potgieter A, Durbin P, Houin G. Clinical pharmacokinetics of acamprosate. Clin Pharmacokinet 1998;35(5):331-45.
17. Baltieri DA, Andrade AG. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients. Rev Bras Psiquiatr 2005;25(3):156-9.
18. Sass H, Soyka M, Mann K, Zieglgänsberger W. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 1996;53(8):675-80.
19. Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol Alcohol 2000;35(2):202-9.
20. Wilde MI, Wagstaff AJ. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 1997;53 (6):1038-63.
21. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J. JAMA. 2000;284(8):963-71